CTRI/2024/05/067252
Not yet recruiting
Phase 3
An open label non comparative prospective clinical trial on the efficacyof BalRasayana syrup as an immunomodulator and its role in recurrentrespiratory tract infections in children - IMB
GURUKRUPA AMRUTA AYURVEDA LLP0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: J209- Acute bronchitis, unspecified
- Sponsor
- GURUKRUPA AMRUTA AYURVEDA LLP
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed as suffering from Vataja Pratishyaya on Ayurvedic parameters
- •Age group of 3 to 16 years.
- •Cardinal features of recurrent respiratory tract infections
- •History of at least 3 episodes in the last six months
Exclusion Criteria
- •Individuals below 3 years and above 16 years
- •Severe and Complicated respiratory allergic disorders like Bronchitis Pneumonia Tuberculosis
- •Emphysema Lung abscess Bronchiectasis
- •Patients who are diagnosed as Chronic asthma
- •Nasal polyposis
- •Congenital anomalies related to the respiratory system
- •Patients on inhaled or systemic steroids
- •Patients who are suspected of any of the diseases mentioned in exclusion criteria on the basis of history and examination will be excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Clinical study to evaluate the Efficacy of Nattokinase as a Nutraceutical supplement for preventing blood clot in Type II Diabetes Mellitus Patients.Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complicationsCTRI/2019/10/021808Dr Debananda Sahoo
Completed
Not Applicable
Cosmetic formulation of a fairness cream in Female and Male subjects to check the fairness effectCTRI/2019/04/018629eeford Healthcare Limited India60
Not yet recruiting
Phase 2
A study to compare the reduction of blood sugar,blood pressure,cholesterol and inflammatory benefits momordica charantia tablet with regular therapy in metabolic syndrome patientsHealth Condition 1: E138- Other specified diabetes mellituswith unspecified complicationsCTRI/2020/06/025569Dr M Shri Vidhya
Not yet recruiting
Phase 4
To evaluate the safety and efficacy of Endotone polyherbal capsule in treatment of Endometriosis.Health Condition 1: N809- Endometriosis, unspecifiedCTRI/2022/10/046666Charak Pharma Pvt Ltd
Completed
Not Applicable
An open-label, prospective, non-comparative clinical trial to evaluate the efficacy and safety of rosuvastatin in high risk Indian population with diabetes and dyslipidemiaDiabetes patients with dyslipidemiaNutritional, Metabolic, EndocrineDyslipidemiaISRCTN22416062Ranbaxy Laboratories Ltd (India)360